ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 250 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $149,000 | -52.5% | 10,566 | -17.7% | 0.00% | – |
| Q1 2022 | $314,000 | -53.9% | 12,841 | -53.4% | 0.00% | -100.0% |
| Q2 2021 | $681,000 | +25.0% | 27,563 | +29.9% | 0.00% | 0.0% |
| Q1 2021 | $545,000 | +58.0% | 21,220 | +228.9% | 0.00% | – |
| Q4 2020 | $345,000 | -52.1% | 6,452 | -63.1% | 0.00% | -100.0% |
| Q3 2020 | $720,000 | -29.8% | 17,490 | -17.4% | 0.00% | -50.0% |
| Q2 2020 | $1,026,000 | +346.1% | 21,165 | +289.3% | 0.00% | +100.0% |
| Q1 2020 | $230,000 | -69.8% | 5,437 | -69.7% | 0.00% | 0.0% |
| Q4 2019 | $762,000 | +166.4% | 17,929 | +125.3% | 0.00% | 0.0% |
| Q3 2019 | $286,000 | +34.9% | 7,959 | +0.8% | 0.00% | – |
| Q1 2019 | $212,000 | -48.0% | 7,896 | -41.8% | 0.00% | -100.0% |
| Q4 2017 | $408,000 | – | 13,557 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |